SAM #NOI-CC-OLAO-26-006363

Sole Source Procurement of Olink Q100 Instrument Reagents for NIH Clinical Center

This notice announces the NIH Clinical Center's intent to negotiate a sole source procurement with Olink Proteomics Inc. for specialized reagents. - The reagents are specifically designed and validated for use with the Olink Q100 Instrument. - Olink Proteomics Inc. is the original equipment manufacturer (OEM) of the Q100 Instrument and the only supplier of compatible reagents. - No other vendors can provide reagents validated for the Olink Q100, making this a sole source requirement. - The statutory authority for this action is 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (only one responsible source). - This is not a request for proposal; however, interested parties may submit capability statements for consideration. - The opportunity is for the supply of Olink reagents only, with no additional products or services listed. - The notice is informational and intended to communicate the sole source intent to the public.

Description

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Olink Proteomics Inc.

Acquistion Description:

Olink Proteomics Inc. is the manufacturer of Q100 Instrument and the only company that sell reagents compatible with the Q100 Instrument. The Olink Q100 Instrument will only validated Olink reagents. No other vendor supplies reagents compatible with the Olink® Q100 Instrument.

The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-006363) by 12:00 PM eastern standard time on 06/21/2026 to: valerie.gregorio@nih.gov.

All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

View original listing